Vera Therapeutics is trading at $29.03, down 4.03%, amid biotech-sector weakness; no clear company-specific announcement explains the decline.
- Recent coverage points to upcoming ASN Kidney Week presentations, not a new negative catalyst.
- XBI is down 2.04% during the regular session.
- Broader risk-off sentiment, elevated yields, and oil-related inflation concerns may also weigh on shares, though major indexes are down less than 0.5%.